Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Asset Utilization Ratio fell 142.14% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2024, down 142.14%, and an annual FY2023 reading of 0.01, changed N/A over the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2024 at Oramed Pharmaceuticals, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q2 2023 and bottomed at 0.0 in Q3 2024.
  • Average Asset Utilization Ratio over 3 years is 0.01, with a median of 0.01 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio crashed 66.92% in 2023, then plummeted 142.14% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.02 in 2022, then plummeted by 66.92% to 0.01 in 2023, then tumbled by 182.27% to 0.0 in 2024.
  • Business Quant data shows Asset Utilization Ratio for ORMP at 0.0 in Q3 2024, 0.0 in Q2 2024, and 0.0 in Q1 2024.